NCT00518271View on ClinicalTrials.gov

Study Comparing Standard Dose and Reduced Dose Tacrolimus + Sirolimus + Corticosteroids in Renal Allograft Recipients

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 30, 2000

Study Completion Date

June 30, 2002

Conditions
Kidney Transplantation
Interventions
DRUG

Rapamune® (Sirolimus)

DRUG

Tacrolimus

DRUG

Corticosteroids

Perioperative

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00518271 - Study Comparing Standard Dose and Reduced Dose Tacrolimus + Sirolimus + Corticosteroids in Renal Allograft Recipients | Biotech Hunter | Biotech Hunter